Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury
Therapeutic interventions following severe traumatic brain injury (TBI) are substantially influenced by complex and interwoven pathophysiological cascades involving both, local and systemic alterations. Our main duty is to prevent secondary progression of the primary damage. This, in turn, obl...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2011-07-01
|
| Series: | Swiss Medical Weekly |
| Subjects: | |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/1319 |
| _version_ | 1797979632141598720 |
|---|---|
| author | J Stover |
| author_facet | J Stover |
| author_sort | J Stover |
| collection | DOAJ |
| description |
Therapeutic interventions following severe traumatic brain injury (TBI) are substantially influenced by complex and interwoven pathophysiological cascades involving both, local and systemic alterations. Our main duty is to prevent secondary progression of the primary damage. This, in turn, obliges us to actively search and identify secondary insults related, for example, to hypoxia, hypotension, uncontrolled hyperventilation, anaemia, and hypoglycaemia. During pharmacological coma we must rely on specific cerebral monitoring which is indispensable in unmasking otherwise occult changes. In addition, extended neuromonitoring (SjvO2, ptiO2, microdialysis, transcranial Doppler sonography, electrophysiological studies, direct brain perfusion measurement) can be used to define individual pathological ICP levels which, in turn, will support our decision making. Extended neuromonitoring expands the limited knowledge derived from ICP and CPP values, thereby allowing us to adequately adapt the type, extent and speed of different therapeutic interventions. A more individualised and flexible treatment concept depends on extended neuromonitoring.
The present review addresses current evidence in favour of extended neuromonitoring used to guide treatment options aimed at improving intensive care treatment of patients with severe TBI. With increasing experience gained by the use of extended neuromonitoring in clinical routine we may expect that the evidence obtained within the individual patient will translate to convincing evidence on a larger scale for the entire study population.
|
| first_indexed | 2024-04-11T05:41:44Z |
| format | Article |
| id | doaj.art-d7bf40eaa850469f84bed4e4a05e5db7 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2024-04-11T05:41:44Z |
| publishDate | 2011-07-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-d7bf40eaa850469f84bed4e4a05e5db72022-12-22T04:42:31ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972011-07-01141293010.4414/smw.2011.13245Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injuryJ Stover Therapeutic interventions following severe traumatic brain injury (TBI) are substantially influenced by complex and interwoven pathophysiological cascades involving both, local and systemic alterations. Our main duty is to prevent secondary progression of the primary damage. This, in turn, obliges us to actively search and identify secondary insults related, for example, to hypoxia, hypotension, uncontrolled hyperventilation, anaemia, and hypoglycaemia. During pharmacological coma we must rely on specific cerebral monitoring which is indispensable in unmasking otherwise occult changes. In addition, extended neuromonitoring (SjvO2, ptiO2, microdialysis, transcranial Doppler sonography, electrophysiological studies, direct brain perfusion measurement) can be used to define individual pathological ICP levels which, in turn, will support our decision making. Extended neuromonitoring expands the limited knowledge derived from ICP and CPP values, thereby allowing us to adequately adapt the type, extent and speed of different therapeutic interventions. A more individualised and flexible treatment concept depends on extended neuromonitoring. The present review addresses current evidence in favour of extended neuromonitoring used to guide treatment options aimed at improving intensive care treatment of patients with severe TBI. With increasing experience gained by the use of extended neuromonitoring in clinical routine we may expect that the evidence obtained within the individual patient will translate to convincing evidence on a larger scale for the entire study population. https://www.smw.ch/index.php/smw/article/view/1319Critical Careevidencemonitoringpathophysiologysecondary brain damagesecondary insults |
| spellingShingle | J Stover Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury Swiss Medical Weekly Critical Care evidence monitoring pathophysiology secondary brain damage secondary insults |
| title | Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury |
| title_full | Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury |
| title_fullStr | Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury |
| title_full_unstemmed | Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury |
| title_short | Actual evidence for neuromonitoring-guided intensive care following severe traumatic brain injury |
| title_sort | actual evidence for neuromonitoring guided intensive care following severe traumatic brain injury |
| topic | Critical Care evidence monitoring pathophysiology secondary brain damage secondary insults |
| url | https://www.smw.ch/index.php/smw/article/view/1319 |
| work_keys_str_mv | AT jstover actualevidenceforneuromonitoringguidedintensivecarefollowingseveretraumaticbraininjury |